Leishmania major infection in BALB/c mice: protection or exacerbation by treatment with different doses of BCG
- 31 December 1993
- journal article
- Published by Elsevier in Research in Immunology
- Vol. 144 (4), 233-243
- https://doi.org/10.1016/0923-2494(93)80100-d
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef proteinGene, 1991
- Exacerbation of experimental murine cutaneous leishmaniasis with CD4+Leishmania major‐specific T cell lines or clones which secrete interferon‐γ and mediate parasite‐specific delayed‐type hypersensitivityEuropean Journal of Immunology, 1991
- Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.The Journal of Experimental Medicine, 1990
- Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis.The Journal of Experimental Medicine, 1989
- BCG: A modifier of immune responses to parasitesParasitology Today, 1989
- Highly efficient action of autocrine mouse interferon-γ expressed via a retroviral vectorEuropean Journal of Immunology, 1988
- Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectorsEuropean Journal of Immunology, 1988
- A limiting dilution assay for quantifying Leishmania major in tissues of infected miceParasite Immunology, 1985
- Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.The Journal of Experimental Medicine, 1984
- Recognition of protozoan parasite antigens by murine T lymphocytes I. Induction of specific T lymphocyte‐dependent proliferative response to Leishmania tropicaEuropean Journal of Immunology, 1979